Original Research

Impact of Diagnostic Testing on Pediatric Patients With Pharyngitis: Evidence From a Large Health Plan


 

References

Results

There were 24 685 treatment episodes for children diagnosed with pharyngitis. Nearly 47% of these episodes included GAS testing and 47% of the tested patients filled an antibiotic prescription. Similarly, 53% of patients were not tested and 49% of untested patients filled an antibiotic prescription. As a result, the 4 groups identified for analysis were evenly distributed: untested and no prescription (26.9%), untested and prescription (26.3%), tested and prescription (21.9%), and tested and no prescription (24.9%) (Figure).

Table 1 presents the descriptive statistics for these 4 patient groups. Note first that the rate of revisits within 28 days is under 5% across all groups. Second, the 2 tested groups have a lower revisit rate than the untested groups: the tested and treated have a revisit rate of 3.3%, and the tested and untreated have a revisit rate of 2.4%, while both the untested groups have a revisit rate of nearly 5%. These small absolute differences in revisit rates across groups were statistically significant.

Factors associated with receiving GAS test

Several factors were found to impact the decision to test (Table 2). Only 9.7% of children were reported to have any ARTI coinfection. As expected, these comorbidities resulted in a significantly lower likelihood of receiving the GAS test: AOM, bronchitis, sinusitis, pneumonia, and URI as comorbid infections had a 48%, 41%, 37%, 63%, and 13% lower likelihood of receiving the GAS test, respectively, than those with no comorbidities. Similarly, children with fever and respiratory symptoms were 35% and 45% less likely to receiving the GAS test, respectively. This is consistent with our expectation that comorbid ARTI infections will lead many providers to forgo testing.

Provider type and patient age also plays a role in receipt of the GAS test. Relative to outpatient facility providers, primary care physicians were 24% more likely and specialty physicians were 38% less likely of employing the GAS test. The child’s age played a significant role in receipt of the GAS test. Children aged 1 to 5 years and 5 to 12 years were 15% and 14% more likely to receive the test compared to children older than 12 years.

Pages

Recommended Reading

Married docs remove girl’s lethal facial tumor in ‘excruciatingly difficult’ procedure
Journal of Clinical Outcomes Management
Long COVID symptoms reported by 6% of pediatric patients
Journal of Clinical Outcomes Management
Stop using Neutrogena and Aveeno spray sunscreen, J&J warns
Journal of Clinical Outcomes Management
FDA warns of potential mechanical concerns with MAGEC devices
Journal of Clinical Outcomes Management
Children and COVID: New vaccinations increase as cases continue to climb
Journal of Clinical Outcomes Management
FDA OKs odevixibat for pruritus associated with rare liver disease
Journal of Clinical Outcomes Management
FDA okays extended-release exenatide for children with T2D
Journal of Clinical Outcomes Management
Practical Application of Self-Determination Theory to Achieve a Reduction in Postoperative Hypothermia Rate: A Quality Improvement Project
Journal of Clinical Outcomes Management
Children and COVID: Vaccinations, new cases both rising
Journal of Clinical Outcomes Management
As common respiratory viruses resurface, children are at serious risk
Journal of Clinical Outcomes Management